Dr. Sullivan is a senior psychiatric geneticist who has been leading large international projects since 2004. He co-founded large consortia (PGC-overall, PGC-MDD, GAIN-MDD, Tobacco and Genetics Consortium, AN Genetics Initiative), was on the leadership and writing teams for others (International Schizophrenia Consortium, PGC-schizophrenia), began the Swedish Schizophrenia Study, is the point person for collaborations of the PGC with ENIGMA and CHARGE, and helped catalyze the formation of multiple new PGC groups (OCD, PTSD, anorexia nervosa, and drugs/alcohol). He was co-PI of a trans-disciplinary NHGRI Center of Excellence in Genomic Science (with Prof Pardo-Manuel de Villena), and was the PI of a large eQTL study. He leads a sizable effort to “decode” the molecular and cellular effects of genetic variation implicated in schizophrenia. He has been a programmer and analyst for over 30 years and has considerable experience in “omics” studies in human and mouse. From 2014-2024, he is funded to spend half his time at UNC and half at the Karolinska Institutet (KI) in Sweden.